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Abstract
Background: Sleep apnea is temporary cessation or absence of breathing during sleep. Significant
increase in blood pressure is clinically seen in apneic episodes. The aim of this study was to examine
sleep apnea syndrome as a risk factor for non- arthritic anterior ischemic optic neuropathy (NAION)
in a case control study.
Methods: Nineteen NAION patients (9 men and 10 women) and 31 age and sex matched control
participants (18 men and 13 women) were evaluated for obstructive sleep apnea syndrome (OSAS).
Full night polysomnography was performed and proportion of OSAS was compared between the
NAION patients and the control group. Other risk factors for NAION such as hypertension, diabetes,
hyperlipidemia, ischemic heart disease and tobacco consumption were also evaluated. Chi square test
and independent samples t-test were used for statistical analysis.
Results: OF the 19 NAION patients, 18 (95%) had OSAS, and of the control group 13 (41.9%) had
OSAS. The frequency of OSAS was significantly higher among NAION patients compared to the
controls (p< 0.001). The Mean Respiratory Disturbance Index (RDI) was 37.65/h SD= 37.61/h in
NAION patients and it was 15.05/h SD= 11.97/h (p= 0.018) in controls. The frequency of diabetes
and hypertension was significantly higher in the NAION patients than in controls.
Conclusion: based on the results of this study, it seems that there is an association between NAION
and OSAS.
Keywords: Non-Arteritic Anterior Ischemic Optic Neuropathy, Obstructive Sleep Apnea Syndrome,
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Introduction
Non-arthritic Anterior Ischemic Optic
Neuropathy (NAION) is a disease charac-
terized by sudden, painless visual loss that
may progress over hours to days. Visual
acuity is almost always decreased and visu-
al field examination reveals altitudinal field
defects. The inferior (visual) field, is in-
volved more than  the superior(visual)
field, particularly in nasal quadrant (1).
This condition is due to retrolaminar optic
nerve infarction because of obstruction or
decreased perfusion through short posterior
ciliary arteries (2). NAION typically occurs
among patients over 50 years of age (3).
The annual incidence rate of the disease is
estimated to be 2.3 -10.3 cases per 100000
persons in all ages (4). The prevalence rate
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of the disease is 0.54 per 1000000 persons
in all ages (5). The exact cause of NAION
is not known; however, some of systemic
conditions accompanied with NAION con-
sist of systemic hypertension (1,4,6,7), is-
chemic heart disease (1,4,6-9) hypercho-
lesterolemia (1,6), stroke (1), smoking
(1,4,7), nocturnal hypotension (1,4,8-10)
and atherosclerosis (1).
Sleep apnea is temporary cessation or ab-
sence of breathing during sleep. Significant
increase in blood pressure is clinically seen
in apneic episodes. The maximal elevations
occur after the resumption of ventilation. If
apneic spells occur continually during
sleep, it may lead to severe decrease in
blood O2 saturation. At this time, elevation
in blood pressure is very severe and it may
rise to 200 mmHg in systolic blood pres-
sure and 120 mmHg in diastolic blood
pressure. Despite the strong effect of hy-
percapnia in vasodilatation of cerebral ves-
sels, cerebral blood flow during sleep de-
creases in apneic patients more than other
people. Several mechanisms which may
explain the association of OSA and
NAION include:  a) Impaired optic nerve
head blood flow auto regulation secondary
to repeated apneas (11); b) Optic nerve
vascular dysregulation secondary to OSA-
induced arterial blood flow variations; c)
Arterial hypertension and arteriosclerosis;
this dysregulation may be due to the imbal-
ance between nitric oxide and endothelia;
d) Platelet activation may cause micro in-
farcts in the optic nerve (12); e) Direct op-
tic nerve damage can occur as a conse-
quence of repetitive or prolonged hypoxia
or increased intracranial pressure during the
repetitive apnea (13).
Considering the mentioned points, it can
be presumed that sleep apnea syndrome can
act as a risk factor for NAION particularly
because most affected patients with
NAION notice their visual loss first after
they wake up (10). This prospective case
control study was designed to evaluate the
association between abstractive sleep apnea
syndrome and NAION, but the methodolo-
gy we used was slightly different from that
of the previous studies. Moreover, we
matched age, which was an important con-
founding factor in previous studies, in the
two groups in this study.
Methods
We designed and conducted a case-
control study. This study was a prospective
age and sex matched case control study
performed over 53 months (February 2007-
Agust 2011). The NAION group consisted
of 19 patients who referred to the Neu-
roophthalmology Clinic of Farabi hospital
in Tehran University of Medical Sciences,
Tehran, Iran. A neurologist and an oph-
thalmologist confirmed the diagnosis. The
inclusion criteria were as follows: Sudden
painless visual loss, optic disk swelling ac-
companied with flame shape hemorrhages
followed by optic disk pallor in ophthal-
moscopy exam, and relative afferent papil-
lary defect and visual field defects con-
sistent with optic neuropathy. To exclude
such diseases as optic neuritis and temporal
arteritis, patients younger than 45 years of
age underwent more investigations includ-
ing magnetic resonance imaging, and those
patients who had erythrocyte sedimentation
rate> 40 mm/h underwent a biopsy to rule
out temporal arteritis. Patients who had
temporal arteritis or other vasculitis were
excluded.
The control group was selected from
those patients who came to a psychiatry
clinic. All persons in the control group
were within the age range of the case
group, no evidence of NAION was found in
them. Moreover, none of them had a histo-
ry of psychiatric disease. Their illness put
them in the category of mild anxiety and
mood disorders, and they were not taking
psychiatric drugs continuously.
For each NAION patient at least one age
and sex matched control was selected.
Written informed consent was obtained
from all cases and controls. Both case and
control groups were studied by a sleep spe-
cialist. To assess the symptoms, a question-
naire and Epworth Sleepiness Scale were
used for each individual. All participants
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were investigated for sleep apnea syndrome
by full night standard polysomnography.
Polysomnography was performed while the
patient was breathing the room air. Electro-
physiological sleep parameters included
Central, occipital EEG, right and left EOG
and submental EMG; periodic limb move-
ments were monitored by anterior tibialis
EMG, airflow, respiratory effort, arterial
pulse oximetry and ECG. Raw data were
manually scored in 30 second epochs for
sleep stages using the Rechtschaffen &
Kales standard criteria (14) Apnea is de-
fined as a decrease in the airflow to 0-20%
of normal that lasts for a period of 10 se-
conds or longer and hypopnea is a decrease
in airflow of 10 seconds or more and is
scored when the decrease of airflow with
desaturation of 3% or decrease of airflow at
least 50% or decrease of airflow is accom-
panied with EEG arousal. Respiratory Dis-
turbance Index (RDI) was computed as the
total of all respiratory events divided by the
total sleep time in hours. An expert sleep
specialist analyzed all of polysomnography
data of all participants in the study manual-
ly. Diagnosis and grading of sleep apnea
syndrome were based on RDI; and the
RDI<5 was regarded as normal, RDI of 5-
20 was defined as a mild disease, RDI of
20-40 was considered as moderate disease
and RDI> 40 as severe disease.
In addition, other risk factors such as hy-
pertension, diabetes mellitus, ischemic
heart disease, and hyperlipidemia and to-
bacco consumption were investigated in
both groups.
Statistical Analysis
The prevalence of qualitative variables in
case and control groups were compared us-
ing chi square test, and continuous varia-
bles were described by mean (SD), and
means were compared by independent
samples t-test. Backward stepwise logistic
regression (with the presence or absence of
NAION as the dependent variable) was
employed to identify variables that were
independently associated with NAION. A
two sided p< 0.05 was considered statisti-
cally significant.
Results
The NAION and control groups consisted
of 19 and 31 participants, respectively (9
men and 10 women in NAION group and
18 men and 13 women in the control
group). The prevalence of diabetes, hyper-
tension, hyperlipidemia and IHD in the
NAION group was more than the control
group, but a significant relationship was
found for diabetes (p< 0.001) and hyperten-
sion (p= 0.001). Only one participant in the
NAION group had a history of cerebrovas-
Table 1. Demographic Characteristics and Clinical Characteristics among NAION cases and controls
Cases (N=19) Controls (N=31) p
Body Mass Index (Mean±SD) 27.8±3.5 27.5±5.2 0.81
Diabetes (n (%)) 9(45%) 1(3.2%) <0.001
Hypertension (n (%)) 13(68.4%) 6(19.6%) 0.001
Hyperlipidemia (n (%)) 3(15%) 0(9.4%) 0.02
Tobacco Consumption (n (%)) 3(20%) 10(20.8%) 0.143
Ischemic Heart Disease (n(%)) 4(21.1%) 2(6.5%) 0.12
Table 2. Polysomnographic and Symptoms Data
Case Control p
Epworth Sleepiness Score 8.8  SD=4.2 7.2  SD=3.9 0.186
Snoring 8(42.1%) 10(32.3%) 0.55
RDI 39.15  SD=38.01 9.03  SD=10.6 0.003
OSAS 18(95%) 13(41.9%) <0.001
Mild 6(33.3%) 7(53.8%) 0.162
Moderate 5(27.8%) 5(38.5%)
Severe 7(38.9%) 1(7%)
Hypoxemia 13(68.4%) 8(32.3%) <0.001
Mean O2 Saturation 91.1  SD=2.75 92.6  SD=2.5 0.055
Lowest O2 Desaturation 76.8  SD=10.86 84.9  SD=8.4 0.005
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cular attack (CVA) (Table 1).
Eighteen (95%) of 19 patients with
NAION had OSAS. According to RDI, 7
(35%) patients had mild disease, 5 (25%)
moderate and 7 (35%) had severe disease.
In the control group, among the 31 partici-
pants, 13 (41.9%) had OSAS, 7 (53.8%)
had mild disease, 5 (38.5%) had moderate
disease and only 1 (7%) had severe OSAS.
There was a significant difference in the
mean RDI between cases and controls
(p=0.018 with 95%CI 4.303-40.902), and
the prevalence of OSAS was significantly
higher in NAION patients than in controls
(p< 0.001) (Table 2).
All significant correlates of NAION were
entered into a Backward Stepwise (Wald)
logistic regression to predict NAION,
OSAS, diabetic mellitus, hyperlipidemia,
and hypertension, and they were all found
to be significant predictors of NAION (Ta-
ble 3). Overall, the model accounted for
47% of the variance in NAION.
Discussion
Only few studies evaluated the associa-
tion between OSAS and NAION. Majon et
al. compared the prevalence of OSAS in 17
NAION patients with 17 age and sex
matched controls and found that 71% of
NAION cases had OSAS diagnosed by
overnight polysomnography compared to
24% prevalence of OSAS in controls
(Pvalue:0.005) (10). Palombi et al. com-
pared the prevalence of OSAS in 27
NAION patients with the prevalence of
OSAS in the general population (15). They
found 89% prevalence of OSAS in NAION
group, and the risk ratio for a NAION pa-
tient to have OSAS was 4.9 compared to
the general population. Stein and col-
leagues after adjusting for confounding var-
iables,  found  that patients diagnosed with
sleep apnea who were not treated with con-
tinuous positive airway pressure (CPAP)
had a 16% increase in the hazard of devel-
oping NAION when compared to controls
without sleep apnea (16).
Another case control study performed by
Li et al. evaluated the association between
OSAS and NAION (17); 73 NAION cases
were compared with 73 age and sex
matched controls using the Sleep Apnea
scale of the Sleep Disorders Questioner
(SA-SDQ). The results of their study re-
vealed that the prevalence of OSAS in
NAION patients and controls was 30.1%
and 17.8%,  respectively; and they also
found that NAION patients were 2.62 times
(95% CI 1.03 to 6.60) more likely to have
OSAS than controls (16,18). These four
studies found an association between
OSAS and NAION, but Behbehani et al.
reported 3 cases of OSAS that developed
NAION despite of being treated with CPAP
(19). In our study, the prevalence of OSAS
was significantly higher among NAION
patients than controls (p< 0.001), and the
prevalence of OSAS in NAION patients
was higher than what was reported in pre-
vious studies such as in Majon et al. Pal-
ombi et al. and Li et al. studies (95% versus
71%, 89% and 30.1%). However, the prev-
alence of OSAS in controls was obviously
higher than other studies such as Majon et
al. and Li et al. studies (35.8% versus 18%
and 17.8%). In our study, 7 (36.8%) of
NAION patients had severe form of OSAS
and only 1 (7.1%) control participant had
severe OSAS. Clinically, it seems that there
is an association between NAION and se-
verity of OSAS, but such an association is
weak statistically (Chi square test p= 0.052)
and perhaps this is due to the small sample
size. In our study, the prevalence of diabe-
tes, hypertension and ischemic heart dis-
ease was significantly higher in NAION
patients than in controls. Therefore, it
Table 3. Logistic Regression on Non-Arthritic Anterior Ischemic Optic Neuropathy
Variable B OR SE p
OSAS 3.335 28.070 1.409 .018
DM 2.839 17.103 1.276 .026
HTN 1.951 7.032 .875 .026
Note: The overall model attained Cox & Snell R2= 0.47
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seems logical to treat OSAS efficiently to
prevent its complications and also evaluate
patients with NAION for OSAS. As de
Groot indicated in his review, several risk
factors have been suggested for NAION
including old age, systemic hypertension,
hypercholesterolemia, diabetes mellitus,
small cup-to disk ratio and sleep apnea.
sleep apnea was found to be 1.5 to 2-fold
more frequent than the rate of the other
identified risk factors typically associated
with NAION (hypertension, diabetes) (20).
In this study, logistic regression analysis
revealed that diabetes mellitus, hyperten-
sion and sleep apnea were significantly as-
sociated with NAION. In addition, sleep
apnea was found to be 1.5 to 4-fold more
frequent than the rate of the other identified
predictive factors (hypertension, diabetes)
associated with NAION. It is noteworthy to
mention that the results of this study along
with the results of other studies can help
analyze the relationship between NAION
and OSA.
Conclusion
The frequency of OSAS in patients with
NAION in our study was very high (95%),
suggesting that OSAS should be screened
in all of NAION patients and NAION
should be screened in all of OSAS patients
(if age> 50).
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